Kestra Medical Technologies Overview
- Year Founded
-
2014
- Status
-
Public
- Employees
-
443
- Stock Symbol
-
KMTS
- Share Price
-
$28.67
- (As of Friday Closing)
Kestra Medical Technologies General Information
Description
Kestra Medical Technologies Ltd is a commercial-stage wearable medical device and digital healthcare company focused on connected monitoring, therapeutic intervention, and data-driven clinical insights for cardiovascular disease. It has developed and is commercializing the Cardiac Recovery System platform, an integrated cardiac recovery ecosystem designed to support patients at elevated risk of sudden cardiac arrest (SCA) during vulnerable periods of recovery. The platform is anchored by the ASSURE Wearable Cardioverter Defibrillator (WCD), which continuously monitors patient heart rhythms and automatically delivers defibrillation therapy when life-threatening ventricular arrhythmias are detected. The platform also includes digital patient engagement and clinical workflow solutions.
Contact Information
Website
www.kestramedical.comCorporate Office
- 3933 Lake Washington Boulevard Northeast
- Suite 200
- Kirkland, WA 98033
- United States
Corporate Office
- 3933 Lake Washington Boulevard Northeast
- Suite 200
- Kirkland, WA 98033
- United States
Kestra Medical Technologies Timeline
Kestra Medical Technologies Stock Performance
As of 13-Nov-2026, Kestra Medical Technologies’s stock price is $28.67. Its current market cap is $1.71B with 59.6M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $28.67 | $28.62 | $17.34 - $31.99 | $1.71B | 59.6M | 408K | -$2.67 |
Kestra Medical Technologies Financials Summary
As of 31-Jul-2026, Kestra Medical Technologies has a trailing 12-month revenue of $107M.
|
In Thousands, USD |
TTM 31-Jul-2026 | FY 2026 30-Apr-2026 | FY 2025 30-Apr-2025 | FY 2024 30-Apr-2024 |
|---|---|---|---|---|
| EV | 1,188,266 | 964,722 | 1,524,376 | |
| Revenue | 106,726 | 95,126 | 59,815 | 27,814 |
| EBITDA | (140,965) | (123,414) | (101,176) | (76,306) |
| Net Income | (149,873) | (131,612) | (113,814) | (94,120) |
| Total Assets | 347,355 | 358,465 | 295,744 | 45,949 |
| Total Debt | 76,446 | 46,791 | 44,311 | 45,169 |
Kestra Medical Technologies Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Kestra Medical Technologies Comparisons
Industry
Financing
Details
Kestra Medical Technologies Competitors (39)
One of Kestra Medical Technologies’s 39 competitors is Agatsa, a Venture Capital-Backed company based in Noida, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Agatsa | Venture Capital-Backed | Noida, India | ||||
| Cardiac Dimensions | Venture Capital-Backed | Kirkland, WA | ||||
| CardioDiagnostics | Private Equity-Backed | Campbell, CA | ||||
| CVRx | Formerly VC-backed | Minneapolis, MN | ||||
| Heartsine | Formerly VC-backed | Belfast, United Kingdom |
Kestra Medical Technologies Patents
Kestra Medical Technologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12694967-B2 | Medical system for establishing communication between devices using code scanning | Active | 04-Apr-2024 | ||
| US-20250229089-A1 | Wcd with fixed rate demand pacing and demand pacing with intrinsic search | Pending | 15-Jan-2024 | ||
| US-20250082251-A1 | Method and system for noise filtering from ecg signals | Pending | 08-Sep-2023 | ||
| US-20240066310-A1 | Garment change and wash detection in a wearable cardioverter defibrillator (wcd) | Pending | 31-Aug-2022 | ||
| US-20260175040-A1 | Wearable medical system (wms) implementing wearable cardioverter defibrillator (wcd) capturing, recording and reporting ambient sounds | Pending | 03-Mar-2022 | A61N1/3993 |
Kestra Medical Technologies Signals
Kestra Medical Technologies Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Kestra Medical Technologies ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
35.21 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Devices
Subindustry
of 209
Rank
Percentile
Kestra Medical Technologies FAQs
-
When was Kestra Medical Technologies founded?
Kestra Medical Technologies was founded in 2014.
-
Where is Kestra Medical Technologies headquartered?
Kestra Medical Technologies is headquartered in Kirkland, WA.
-
What is the size of Kestra Medical Technologies?
Kestra Medical Technologies has 443 total employees.
-
What industry is Kestra Medical Technologies in?
Kestra Medical Technologies’s primary industry is Therapeutic Devices.
-
Is Kestra Medical Technologies a private or public company?
Kestra Medical Technologies is a Public company.
-
What is Kestra Medical Technologies’s stock symbol?
The ticker symbol for Kestra Medical Technologies is KMTS.
-
What is the current stock price of Kestra Medical Technologies?
As of 13-Nov-2026 the stock price of Kestra Medical Technologies is $28.67.
-
What is the current market cap of Kestra Medical Technologies?
The current market capitalization of Kestra Medical Technologies is $1.71B.
-
What is Kestra Medical Technologies’s current revenue?
The trailing twelve month revenue for Kestra Medical Technologies is $107M.
-
Who are Kestra Medical Technologies’s competitors?
Agatsa, Cardiac Dimensions, CardioDiagnostics, CVRx, and Heartsine are some of the 39 competitors of Kestra Medical Technologies.
-
What is Kestra Medical Technologies’s annual earnings per share (EPS)?
Kestra Medical Technologies’s EPS for 12 months was -$2.67.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process